Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6900
+0.0200 (1.20%)
NASDAQ · Last Trade: Feb 18th, 2:58 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors